Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Auren Rx vs Nalena

Auren Rx
Graded #79

Higher grade

vs+1.7
Nalena
Graded #102

Lower grade

The verdict

Auren Rx takes it — 72.9/100 to 71.2/100, but only just.

Auren Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Auren Rx charges the same $149 for semaglutide and tirzepatide, which removes the usual reason to start on the weaker molecule. Nalena is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
74
74
Dose & formulationEven
64
64
Clinical oversightAuren Rx +1
83
82
Labs & monitoringEven
53
53
FulfillmentAuren Rx +8
97
89
Contract termsAuren Rx +6
67
61
Auren Rx · left barNalena · right bar

The numbers

MetricAuren RxNalena
WeighScore72.9/10071.2/100
GradeCC
Scorecard rank#79#102
Semaglutide$149/mo (auto-refill; a single month with no commitment is $179)$149/mo (starting dose, compounded)
Tirzepatide$149/mo (auto-refill; a single month with no commitment is $179)$149/mo (starting dose, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Auren Rx

Graded #79 · C

Strengths

  • Semaglutide and tirzepatide cost the same, so the choice of molecule is clinical rather than budgetary
  • A microdose lane is priced separately at $129 on auto-refill rather than folded into the standard figure
  • Names its dispensing pharmacy, VialsRX, with a street address and a phone number in Houston, Texas
  • Names a prescribing physician and practice, and publishes support hours of Monday to Friday, 9 AM to 6 PM Eastern

Where it loses points

  • The $149 figure requires enrolling in auto-refill; a single month with no commitment is $179
  • Two different medical groups are named for the same service — Wasef Health, PC on the contact page and FAQ, Beluga Health, P.A. in the telehealth consent
  • Product pages advertise a free online visit while the Terms make the initial online visit and any laboratory testing the patient's responsibility
  • The FAQ says all 50 states, the Terms say service is available only in certain states, and no list is published
  • No compounding class is stated for VialsRX, so whether it operates under 503A or 503B is unknown
  • NAD+ is priced at two different figures on the same site, which is not reassuring about the GLP-1 numbers
Nalena

Graded #102 · C

Strengths

  • Compounded GLP-1 from $149/mo with medication included — near the floor of the compounded market
  • Transparent fee model: no hidden fees, no membership, cancel anytime
  • Money-back guarantee — uncommon among compounded telehealths
  • Clinical provider disclosed: Beluga Health, P.A. in Houston, TX
  • Women-focused positioning

Where it loses points

  • Per-dose pricing not published — only the 'starting at $149' entry price
  • No LegitScript, HIPAA, or NABP badges on public pages
  • Compounding pharmacy partners not named (only 'multiple USA certified pharmacies')
  • Houston address looks like a virtual office rather than a clinical facility
  • No brand-name GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro) — compounded only

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard